Aníbal Ferreira, MD, PhD, FERA Dr. Ferreira earned his MD and PhD in medicine from NOVA Medical School, as well as a master’s degree in PADIS – Senior Management Program for Health Institutions. His research interests focus on various topics, including nephrology, bone disease, and chronic kidney disease. He has authored / co-authored of more than 120 articles, published in peer-reviewed journals, such as Nephrology Dialysis Transplantation, Kidney International, Clinical Kidney Journal and Bone, as well as 8 book chapters. Professor Ferreira was president of the Portuguese Society of Nephrology between 2015–2018 and 2018–2021, and Vice Dean from NOVA Medical School between 2022-2025.

João Sérgio Neves is an endocrinologist at Hospital de São João. He holds a PhD in Cardiovascular Sciences from the Faculty of Medicine of the University of Porto (FMUP) and teaches the curricular units of Physiology, Pathophysiology, and Endocrine Diseases, Nutrition and Metabolism. He is a researcher at RISE-Health and has published more than 150 articles in indexed journals with impact factor, as well as over 500 conference abstracts. He has received more than 70 scientific and academic awards. He currently serves as Vice-President of the Pedagogical Council of FMUP and Secretary-General of the Portuguese Society of Endocrinology, Diabetes and Metabolism.

Inês Alencastre is a Researcher at RISE‑Health|Faculty of Medicine, University of Porto (FMUP), Coordinator of the Nephrology and Cardiovascular Risk Laboratory, and Invited Professor at FMUP. She holds a degree in Biochemistry and a PhD in Biomedical Sciences from UP. Throughout her career, she has investigated fundamental biochemical pathways across diverse pathologies, including cancer (SUGEN Inc., USA), neurodegenerative diseases (IBMC, Portugal), organelle biogenesis disorders (IBMC, Portugal) and bone regeneration (i3S, Portugal) and, more recently, kidney diseases (RISE‑Health|FMUP), which now constitute the central and most intellectually compelling drive of her research. Presently, her research focuses in the investigation of the environment-specific cellular and molecular mechanisms underlying chronic kidney disease (CKD) as a mean to discover biomarkers and therapeutic targets for CKD and associated comorbidities, in particular, cardiovascular disease and renal osteodystrophy. She is deeply committed to translating mechanistic discoveries into clinically meaningful advances that may improve outcomes for CKD patients.